Guest guest Posted September 9, 2008 Report Share Posted September 9, 2008 Proton therapy systems are exceedingly difficult to develop. While currently dominated by European and Japanese manufacturers, like the Belgian company IBA, German ACCEL Instruments, and Hitachi of Japan, US proton therapy developers are making great strides. Enter ProTom International, a Texas-based company, which just announced collaborative agreement with MIT's Bates Linear Accelerator Center "for the testing and calibration of an advanced proton synchrotron technology for cancer treatment."Click on below link for full story:<http://www.medgadget.com/archives/2008/09/protom_proton_therapy_technology_gets_a_boost.html> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.